ConductScience.org, home

Paper197922

Strand scission of DNA by bound adriamycin and daunorubicin in the presence of reducing agents.

Lown JW and 3 others. Biochem Biophys Res Commun, 1977. Cited by 216 papers, by iCite.

Cite this record

ConductScience Library. Strand scission of DNA by bound adriamycin and daunorubicin in the presence of reducing agents. Papers, record 197922. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/197922

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Strand scission of DNA by bound adriamycin and daunorubicin in the presence of reducing agents.
PubMed
Journal
Biochem Biophys Res Commun
PubMed
Year
1977
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
216
iCite
Relative citation ratio, by iCite
8.26
iCite
Revised in PubMed
2019-06-12
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Lown JWJ W
2Sim SKS K
3Majumdar KCK C
4Chang RYR Y

Source PubMed

Download CSV of authors

Topics8

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
DNA, CircularMajor topic
DNA, ViralMajor topic
DaunorubicinMajor topic
DoxorubicinMajor topic
Binding Sites
Nucleic Acid Conformation
Oxidation-Reduction
Superoxides

Source PubMed

Download CSV of topics

Cited by30

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 216 citations.

PMIDTitleJournalYearIn PapersSource
34681173Activity of New Synthetic (2-Chloroethylthio)-1,4-naphthoquinones in Prostate Cancer Cells.Pharmaceuticals (Basel)2021https://conductscience.org/library/papers/34681173PubMed
32403427Inspired by Sea Urchins: Warburg Effect Mediated Selectivity of Novel Synthetic Non-Glycoside 1,4-Naphthoquinone-6S-Glucose Conjugates in Prostate Cancer.Mar Drugs2020https://conductscience.org/library/papers/32403427PubMed
31671612Successful Targeting of the Warburg Effect in Prostate Cancer by Glucose-Conjugated 1,4-Naphthoquinones.Cancers (Basel)2019https://conductscience.org/library/papers/31671612PubMed
30465055Rutin and orlistat produce antitumor effects via antioxidant and apoptotic actions.Naunyn Schmiedebergs Arch Pharmacol2019https://conductscience.org/library/papers/30465055PubMed
27002730RGS6 as a Novel Therapeutic Target in CNS Diseases and Cancer.AAPS J2016https://conductscience.org/library/papers/27002730PubMed
24092333Enhancing cell nucleus accumulation and DNA cleavage activity of anti-cancer drug via graphene quantum dots.Sci Rep2013https://conductscience.org/library/papers/24092333PubMed
21859827Regulator of G protein signaling 6 mediates doxorubicin-induced ATM and p53 activation by a reactive oxygen species-dependent mechanism.Cancer Res2011https://conductscience.org/library/papers/21859827PubMed
16653223The Effect of 5OH-1,4-Naphthoquinone on Norway Spruce Seeds during Germination.Plant Physiol1992https://conductscience.org/library/papers/16653223PubMed
8037673One- and two-electron reduction of 2-methyl-1,4-naphthoquinone bioreductive alkylating agents: kinetic studies, free-radical production, thiol oxidation and DNA-strand-break formation.Biochem J1994https://conductscience.org/library/papers/8037673PubMed
7923547Hypoxia and drug resistance.Cancer Metastasis Rev1994https://conductscience.org/library/papers/7923547PubMed
7894775Epidermal growth factor, phorbol esters, and aurintricarboxylic acid are survival factors for MDA-231 cells exposed to adriamycin.In Vitro Cell Dev Biol Anim1994https://conductscience.org/library/papers/7894775PubMed
7765324Glutathione-related enzymes, glutathione and multidrug resistance.Cytotechnology1993https://conductscience.org/library/papers/7765324PubMed
7686469Epirubicin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in cancer chemotherapy.Drugs1993https://conductscience.org/library/papers/7686469PubMed
7076716Covalent protein binding of reactive adriamycin metabolites in rat liver and rat heart microsomes.J Cancer Res Clin Oncol1982https://conductscience.org/library/papers/7076716PubMed
7035210Toxic drug effects associated with oxygen metabolism: redox cycling and lipid peroxidation.Experientia1981https://conductscience.org/library/papers/7035210PubMed
6353197The mechanism of action of quinone antibiotics.Mol Cell Biochem1983https://conductscience.org/library/papers/6353197PubMed
6324188Mechanism of antitumor drug action: poisoning of mammalian DNA topoisomerase II on DNA by 4'-(9-acridinylamino)-methanesulfon-m-anisidide.Proc Natl Acad Sci U S A1984https://conductscience.org/library/papers/6324188PubMed
6295265Mechanism of action of dnacin B1, a new benzoquinoid antibiotic with antitumor properties.Antimicrob Agents Chemother1982https://conductscience.org/library/papers/6295265PubMed
6285890Reactions of Adriamycin with haemoglobin. Superoxide dismutase indirectly inhibits reactions of the Adriamycin semiquinone.Biochem J1982https://conductscience.org/library/papers/6285890PubMed
3913602A chemical perspective on the anthracycline antitumor antibiotics.Environ Health Perspect1985https://conductscience.org/library/papers/3913602PubMed

See all 30 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/197922

GET https://conductscience.org/api/papers/v1/197922/cited_by?page=2